129 related articles for article (PubMed ID: 37721757)
1. Anti-Epidermal Growth Factor Receptor Maintenance Therapy in Metastatic Colorectal Cancer-Another Piece to the Puzzle.
Morano F; Pietrantonio F
JAMA Netw Open; 2023 Sep; 6(9):e2333488. PubMed ID: 37721757
[No Abstract] [Full Text] [Related]
2. Middle East and North Africa Registry to Characterize Rate of RAS Testing Status in Newly Diagnosed Patients with Metastatic Colorectal Cancer.
Oukkal M; Bouzid K; Bounedjar A; Alnajar A; Taleb FA; Alsharm A; Mahfouf H; Larbaoui B; Abdelaziz A; Ouamer A; Bashir L
Turk J Gastroenterol; 2023 Feb; 34(2):118-127. PubMed ID: 36445057
[TBL] [Abstract][Full Text] [Related]
3. The screening with the liquid biopsy for the rechallenge with anti-epidermal growth factor receptor antibodies in metastatic colorectal cancer A perspective based on pharmacological costs.
Giuliani J; Mantoan B; Candela MV; Napoli G; Muraro M; Mangiola D; Mandara M
Recenti Prog Med; 2023 Sep; 114(9):563-564. PubMed ID: 37530025
[No Abstract] [Full Text] [Related]
4. Risk factor analysis for anti-epidermal growth factor receptor monoclonal antibody-induced skin toxicities in real-world metastatic colorectal cancer treatment.
Saito Y; Uchiyama K; Takekuma Y; Komatsu Y; Sugawara M
Support Care Cancer; 2023 Aug; 31(8):504. PubMed ID: 37528282
[TBL] [Abstract][Full Text] [Related]
5. A review on emerging targeted therapies for the management of metastatic colorectal cancers.
Deshmukh R; Prajapati M; Harwansh RK
Med Oncol; 2023 Apr; 40(6):159. PubMed ID: 37097307
[TBL] [Abstract][Full Text] [Related]
6. Maintenance Therapy With Cetuximab After FOLFIRI Plus Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial.
Boige V; Blons H; François E; Ben Abdelghani M; Phelip JM; Le Brun-Ly V; Mineur L; Galais MP; Villing AL; Hautefeuille V; Miglianico L; De La Fouchardière C; Genet D; Levasseur N; Levaché CB; Penel N; Mitry E; Jacquot S; Aparicio T; Brument E; Gourgou S; Castan F; Bouché O
JAMA Netw Open; 2023 Sep; 6(9):e2333533. PubMed ID: 37721754
[TBL] [Abstract][Full Text] [Related]
7. Patterns of use and tolerance of anti-epidermal growth factor receptor antibodies in older adults with metastatic colorectal cancer.
Dotan E; Devarajan K; D'Silva AJ; Beck A; Kloth DD; Cohen SJ; Denlinger C
Clin Colorectal Cancer; 2014 Sep; 13(3):192-8. PubMed ID: 25074246
[TBL] [Abstract][Full Text] [Related]
8. Depth of response of induction therapy and consecutive maintenance treatment in patients with RAS wild-type metastatic colorectal cancer: An analysis of the PanaMa trial (AIO KRK 0212).
Sommerhäuser G; Kurreck A; Beck A; Fehrenbach U; Karthaus M; Fruehauf S; Graeven U; Mueller L; Koenig AO; V Weikersthal LF; Goekkurt E; Haas S; Stahler A; Heinemann V; Held S; Alig AHS; Kasper S; Stintzing S; Trarbach T; Modest DP
Eur J Cancer; 2023 Jan; 178():37-48. PubMed ID: 36399909
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy: a prespecified secondary analysis of the PanaMa (AIO KRK 0212) trial.
Ballhausen A; Karthaus M; Fruehauf S; Graeven U; Müller L; König AO; von Weikersthal LF; Sommerhäuser G; Alig AHS; Goekkurt E; Meyer-Knees JW; Kurreck A; Stahler A; Held S; Kasper S; Heinrich K; Heinemann V; Stintzing S; Trarbach T; Modest DP
Eur J Cancer; 2023 Sep; 190():112955. PubMed ID: 37454537
[TBL] [Abstract][Full Text] [Related]
10. [A study of epidermal growth factor receptor in human colorectal cancer].
Liu G; Jiang R
Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):89-92. PubMed ID: 7656813
[TBL] [Abstract][Full Text] [Related]
11. Reduced survival of rectal cancer patients with increased tumor epidermal growth factor receptor levels.
Kopp R; Rothbauer E; Mueller E; Schildberg FW; Jauch KW; Pfeiffer A
Dis Colon Rectum; 2003 Oct; 46(10):1391-9. PubMed ID: 14530681
[TBL] [Abstract][Full Text] [Related]
12. Effect of DNA methylation status on first-line anti-epidermal growth factor receptor treatment in patients with metastatic colorectal cancer.
Osumi H; Ouchi K; Shinozaki E; Takahashi S; Ooki A; Nakayama I; Wakatsuki T; Ogura M; Takahari D; Chin K; Yamaguchi K; Ishioka C
Int J Colorectal Dis; 2022 Jun; 37(6):1439-1447. PubMed ID: 35612620
[TBL] [Abstract][Full Text] [Related]
13. [Metastatic colorectal cancer-Modern treatment strategies and sequences].
Ettrich TJ; Schuhbaur JS; Seufferlein T
Inn Med (Heidelb); 2023 Jun; 64(6):546-559. PubMed ID: 37222756
[TBL] [Abstract][Full Text] [Related]
14. Place of anti-EGFR therapy in older patients with metastatic colorectal cancer in 2020.
Gilabert M; Ries P; Chanez B; Triby S; Francois E; Lièvre A; Rousseau F
J Geriatr Oncol; 2020 Nov; 11(8):1229-1236. PubMed ID: 32451314
[TBL] [Abstract][Full Text] [Related]
15. Human Epidermal Growth Factor 2 in Metastatic Colon Cancer: A Familiar Target in a New Setting.
Cai J; Chiu VY
JCO Oncol Pract; 2022 Aug; 18(8):557-558. PubMed ID: 35947878
[No Abstract] [Full Text] [Related]
16. [Colorectal cancers: surgery of non-metastatic colonic and rectal cancer].
Nordlinger B; Benoist S
Pathol Biol (Paris); 2004 Apr; 52(3):117-8. PubMed ID: 15063928
[No Abstract] [Full Text] [Related]
17. Epidermal growth factor receptors in colorectal carcinoma.
Moorghen M; Ince P; Finney KJ; Watson AJ; Harris AL
Anticancer Res; 1990; 10(3):605-11. PubMed ID: 2195985
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of advanced and/or metastatic colorectal cancer with bevacizumab in combination with oxaliplatin-based chemotherapy (Folfox7 regimen)].
Oukkal M; Djilat K; Hadjam RM; Mahgoun M; Bentabak K; Graba A; Smail N; Kaci NA; Ahmed RB; Bouzid K
Bull Cancer; 2010 Apr; 97(4):469-74. PubMed ID: 20385517
[TBL] [Abstract][Full Text] [Related]
19. Durable complete response to immunotherapy in treatment-resistant metastatic colorectal cancer with thyroid transcription factor 1 expression.
Hanna M; Guerra G; O'Byrne K
ANZ J Surg; 2020 Nov; 90(11):E97-E99. PubMed ID: 32142186
[No Abstract] [Full Text] [Related]
20. Multiple Acquired Mutations Captured by Liquid Biopsy in the EGFR Addicted Metastatic Colorectal Cancer.
Guerrera LP; Napolitano S; De Falco V; Giunta EF; Vitiello PP; Gravina AG; Suarato G; Perrone A; Napolitano R; Martinelli E; Ciardiello F; Troiani T
Clin Colorectal Cancer; 2021 Dec; 20(4):354-358. PubMed ID: 34454840
[No Abstract] [Full Text] [Related]
[Next] [New Search]
